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Synopsis: The relationship between reticular pseudodrusen and coronary artery 20 
disease was evaluated using ultra-widefield retinal imaging.  Validation was performed 21 
separately and satisfactorily using other imaging modalities.No association between 22 
coronary artery disease and reticular pseudodrusen was found. 23 
ABSTRACT 24 
Purpose: Reticular pseudodrusen (RPD) is a risk factor for late age-related 25 
macular degeneration (AMD). Associations between RPD and coronary artery 26 
disease (CAD) have been reported from small case-control studies. This study 27 
investigated the association of RPD within a predominantly CAD cohort. 28 
Methods: A subgroup of subjects from a multicenter randomized controlled trial 29 
of computed tomography coronary angiography (CTCA) underwent ultra-30 
widefield (UWF) retinal imaging CAD determined by CTCA was categorized as 31 
normal, non-obstructive or obstructive. Specific AMD features in UWF images 32 
were graded. Standardized grids were used to record the spatial location of AMD 33 
features, including RPD. Multivariate confounder adjusted regression models 34 
assessed the association between RPD and CAD. 35 
Results: The 534 participants were aged from 27-75 years (mean 58 ±9 years; 36 
425 (80%) ≥50 years) with a male preponderance (56%). Within the study 37 
sample, 178 (33%) had no CAD, 351 (66%) had CAD. RPD was detected in 30 38 
participants (5.6%) and bilaterally in 23. Most participants with bilateral RPD had 39 
intermediate AMD 17 (74%). After adjustment for potential confounders (age, 40 
sex, drusen >125 µm, smoking status), multivariate analysis found no significant 41 
association between CAD and RPD (odds ratio [OR] 1.31; 95% Confidence 42 
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Interval [CI] (0.57-3.01); p=0.52). A significant association was identified between 43 
RPD and intermediate AMD (OR 3.18; 95% CI (1.61-6.27); p= 0.001). 44 
Conclusion: We found no evidence to support an association between CAD and 45 
RPD. RPD was strongly associated with intermediate AMD features.  46 
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INTRODUCTION 47 
Age-related macular degeneration (AMD) is the leading cause of permanent blindness 48 
in the developed world with the most sight loss occurring in the late stages, namely 49 
geographic atrophy (GA) and choroidal neovascularization (CNV).1  Risk factors for 50 
progression from early to late AMD include advancing age, cardiovascular disease 51 
(CVD), obesity, cigarette smoking,  ethnicity, hypertension, high cholesterol, genetic 52 
variants such as age-related maculopathy susceptibility 2 (ARMS2) gene, complement 53 
factor H (CFH) and apolipoprotein E (ApoE) gene and inflammatory markers such as 54 
C-reactive protein (CRP).2 Recently, reticular pseudodrusen (RPD) have been shown 55 
to be an important independent risk factor for progression to both GA3,4 and CNV.3,5 56 
In addition, various risk factors have been reported to be associated with RPD 57 
including advancing age, female gender, smoking, ARMS2, C3, VEGFA and CFH 58 
genetic variants.6-8 59 
 60 
RPD is a subtype of AMD associated with subretinal drusenoid deposits (SDD) and is 61 
located between the retinal pigment epithelium (RPE) and the inner ellipsoid zone.6 62 
Associations between RPD, SDD, reticular macular disease (RMD) and coronary 63 
artery disease (CAD) have been reported from small case-control studies. The 64 
acronyns and associated full titles are mentioned here in order to avoid any confusion. 65 
In particular, the term SDD is preferred for the actual physical deposits as first 66 
recognized within histopathology by Curcio et al.9  67 
 68 
In association with the selection of image modality, variations in specific definitions of 69 
RPD have also led to substantial differences in reported prevalence rates. Initial 70 
reports of the association came from data collected on AMD cohorts recruited in 71 
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hospital eye clinics and reported high prevalences ranging from 29 - 52%. 6, 10,11  Data 72 
from population based studies are limited and show large variation, such as 0.4% from 73 
the Melbourne Collaborative Cohort study to 4.9% in the Rotterdam study and 13% in 74 
the Alienor study.7,8,12 Such varying estimates might be attributed to the different 75 
imaging and grading protocols used.  76 
 77 
The strong association between RPD and a thin choroid has prompted a spate of small 78 
studies that have sought associations between RPD and cardiovascular disease.13-17 79 
Cymerman et al reported on a small prospective cohort of patients with no known 80 
retinal disease recruited from a cardiovascular clinic; 23 participants with coronary 81 
artery disease (CAD) had a higher frequency of RPD compared to 15 who did not have 82 
CAD.13 A review by Rastogi and Smith14 on the association between AMD, RPD and 83 
CVD highlighted studies reporting an association between RPD and hypertension and 84 
angina.15-18 Smith and colleagues hypothesized that the increased mortality from 85 
systemic-vascular disease that affects males more severely compared to females, 86 
may account for the higher proportion of women with RPD that has been observed in 87 
various population-based studies.18 Notably this review highlighted the potential 88 
importance of large prospective cohort studies sampling participants >45 years with 89 
and without CAD to identify RPD development and potential associations.14  90 
 91 
A sub-study of the SCOT-HEART (SH) trial that incorporated only ultrawide field 92 
(UWF) retinal imaging offered an unique opportunity to explore the relationship 93 
between CAD and RPD. The use of widefield technology to evaluate the retinal fundus 94 
offered an additional advantage as RPD is commonly located in the retinal arcades 95 
and beyond.15 To date there is one study that has estimated RPD prevalence that has 96 
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included central and peripheral retinal locations.19  In this study, RPD were present in 97 
15% of AMD subjects in zone 2, but none in the controls, a difference that was  98 
significant. However the sensitivity of UWF to detect RPD has not been established. 99 
We therefore first validated the methodology using images from a population based 100 
epidemiological study (the Northern Ireland Cohort for the Longitudinal Study of 101 
Ageing [NICOLA]) which captured UWF, color fundus photography (CFP), infra-red 102 
(IR) and autofluorescence (AF) images of the retina, and subsequently used the SH 103 
trial sub-study UWF images to explore the relationship between RPD and CAD. 104 
MATERIALS AND METHODS 105 
Validation of detection of RPD by UWF imaging 106 
Nine hundred consecutive participants were selected from the NICOLA Study. CFP 107 
was performed on the Canon CX-1 Digital Fundus Camera (Canon U.S.A., Inc., 108 
Melville, NY, U.S.A.). Stereoscopic pairs centered on the optic disc and macula were 109 
captured. CFP images were viewed and graded using the Oculab program (Digital 110 
Healthcare Oculab, V3.7.98.0, Emis Health, Leeds, UK). UWF retinal imaging was 111 
performed on the Optos Tx200 Scanning Laser Ophthalmoscope (Optos PLC, 112 
Dunfermline, UK)  using both color and AF acquisition modes. Images were viewed 113 
and graded using the Optos V2 Vantage Pro software (version 2.9.4.2).  114 
UWF images were graded for the presence or absence of RPD by a trained single 115 
grader who was not involved in any other grading procedures with quality assurance 116 
and review by a retina specialist (UC). All available imaging modalities were used to 117 
determine the presence of RPD. This included en face images of color, multicolor, AF 118 
and IR. In addition high resolution optical coherence tomograms were also scrutinized 119 
for the presence of SDD. The image grading was undertaken by trained graders in the 120 
network of UK Reading Center’s (NetwORC UK) for the presence or absence of RPD. 121 
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Detection of RPD on any modality was taken as evidence of presence of this feature. 122 
Sensitivity and specificity of the UWF imaging in detecting RPD compared to the RPD 123 
detected from the NICOLA cohort’s en face and tomographic images was computed. 124 
 125 
The SCOT-HEART (SH) Study and Sample 126 
The SH trial (ClinicalTrials.gov, number NCT01149590) was a multicenter randomized 127 
controlled trial undertaken in Scotland (2010-2014) on 4,146 participants, aged 18-75 128 
years, drawn from 12 cardiology clinics across Scotland.20 The main aim of the study 129 
was to determine the role of multidetector computed tomography in the diagnosis and 130 
management of patients attending rapid access chest pain clinics. Participants were 131 
randomly assigned to either standard care (control intervention) or standard care and 132 
the computed tomography coronary angiography (CTCA) and calcium scores 133 
(intervention). CAD was categorized in the SH study as: (i) obstructive CAD, 134 
atherosclerotic plaque encompassing a luminal cross-sectional area of ≥70% in at 135 
least one major epicardial vessel; (ii) non-obstructive CAD, either atherosclerotic 136 
plaque encompassing a luminal cross-sectional area of <70% but >10% in at least one 137 
major epicardial vessel, or a calcium score >400 AU (Agatston units) or >90th 138 
percentile for age and sex; or (iii) minimal or no CAD. Non-obstructive disease was 139 
further sub-divided into mild (10-50% luminal cross-sectional area) or moderate (50-140 
70% luminal cross-sectional area) stenosis.  At two sites (Edinburgh and Dundee), 141 
consecutive patients were approached to undergo UWF imaging immediately before 142 
or after undergoing CTCA. We assessed 534 participants from a sub-study of SH who 143 
had UWF imaging captured using two Optos P200C Scanning Laser 144 
Ophthalmoscopes (Optos PLC, Dunfermline, UK) in addition to the normal study 145 
8 
 
procedures at two sites (the Clinical Research Imaging Center in Edinburgh and the 146 
Clinical Research Center Dundee).21 147 
 148 
Image Grading in SH 149 
Specific features of AMD in UWF images were graded for AMD characteristics 150 
(increased pigment, decreased pigment, drusen, maximum drusen size, RPD, GA and 151 
CNV) and other peripheral abnormalities using the ‘Study-specific Grading Procedures 152 
for OPERA Study,’ guidelines (November 2013).22 The Optos software utilised a 153 
modified Studies of Ocular Complications of AIDS (SOCA) Optos PEripheral RetinA 154 
study (OPERA) grid (Figure 1) which was divided into three zones: Zone 1 (posterior 155 
pole), Zone 2 (extends from Z1 to a circle through the ampullae of the vortex veins) 156 
and Zone 3 (extends from Z2 to the outer periphery). The Manchester grid was 157 
superimposed on the SOCA grid to estimate the ungradable areas (Figure 2). In 158 
accordance with the OPERA guidelines, at least 50% of the subfield should be visible 159 
to grade; if < 50% of the subfield was visible, it was graded as “Cannot Grade.” If AMD 160 
characteristics and other pathologies were present in a Cannot Grade subfield, and if 161 
the grader was ≥ 90% certain the lesion was present, then grading was ascribed. 162 
Drusen presence was graded as follows: absent; questionable; 1-5 drusen; 6-20 163 
drusen; >20 drusen or cannot grade. The maximum drusen size was graded as 164 
follows: < 125µm; ≥ 125µm, < 250µm distinct; ≥ 125µm, < 250µm indistinct; ≥ 250µm 165 
distinct; ≥ 250µm indistinct or cannot grade. RPD was graded as follows: absent; 166 
questionable; < 25% of subfield; 25-49% of subfield; 50-74% of subfield; ≥ 75% of 167 
subfield or cannot grade. RPD were defined as yellow interlacing networks ranging 168 
from 125µm to 250µm in width or lesions that occurred in regular well-defined domains 169 
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(Figure 3). Images in which RPD were questionable were arbitrated by a retinal 170 
specialist (UC).  171 
 172 
Statistical Analysis 173 
Statistical analyses were performed using IBM SPSS Statistics version 20 174 
(Portsmouth, UK). Intraobserver agreement was calculated after 1 in 20 of the images 175 
were randomly regraded for RPD and drusen using kappa (k) statistics, which express 176 
the extent of agreement beyond chance. The interpretation of the k statistic was as 177 
follows: 0, no agreement; 0 to 0.2, slight agreement; 0.21 to 0.40, fair agreement; 0.41 178 
to 0.60, moderate agreement; 0.61 to 0.8, substantial agreement; and >0.81, almost 179 
perfect agreement.23  180 
 181 
Univariate analysis (Chi-squared test or Fisher’s Exact test for categorical variables 182 
and independent t-test for continuous variables) was used to examine differences in 183 
the demographic characteristics of participants according to presence or absence of 184 
RPD. General estimating equations (GEE) which enabled data from both eyes to be 185 
included were used to examine the association between RPD and CAD while 186 
accounting for other factors identified as significant from the univariate analysis.  187 
 188 
RESULTS 189 
Validation study 190 
The sensitivity and specificity of UWF was compared with enface and tomographic 191 
multimoda images in the detection of RPD. Of the images acquired from the 900 192 
consecutive participants included in the validation study, UWF imaging detected 8 193 
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participants with reticular drusen (2 unilateral and 6 bilateral; 100% sensitivity). 194 
Multimodal imaging (color, multicolor, infra-red and autofluorescence and OCT) 195 
detected RPD in 7 of those which were seen on en face images  The specificity of the 196 
UWF imaging was 99.9%. In one case, the UWF imaging detected RPD beyond the 197 
field of view captured by the combination of retinal imaging (Figure 4). The positive 198 
predictive value (PPV) was calculated at 87.5% and the negative predictive value 199 
(NPV) was 100%.  200 
 201 
Participant Characteristics in SH study 202 
Table 1 summarizes SH study participant characteristics. In total 534 individuals 203 
had UWF retinal images captured.  Two participants [4 eyes] proved difficult to 204 
scan and images were not obtained. This left 532 pairs of eyes for grading. The 205 
mean age was 58 years (range=27-75, SD 9.5) with 425 (80%) aged over 50 206 
years. There were 299 males (56%). 178 (33%) had no CAD, 351 (66%) had 207 
CAD present, whilst 182 (34%) had hypertension and 42 (24%) had no CAD or 208 
hypertension. 209 
 210 
The intragrader agreement illustrated in Table 2 gives the kappa range for the AMD 211 
features: for the presence of RPD it ranged from: 0.62-0.76; for drusen: 0.58-0.64, 212 
maximum drusen size: 0.55-0.62, increased pigment: 0.54-0.61, decreased pigment: 213 
0.55-0.62; for GA: 0.62-0.76; for neovascular AMD: 0.57-0.66 and for peripheral 214 
abnormality: 0.55-0.59 within zones 1-3. For the lesions which were absent in the 215 
cohort the discordance in the grading originated from a change of grade of feature 216 
absent to ungradeable between the two gradings. 217 
 218 
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Prevalence of RPD and AMD features in the SH study 219 
RPD was present in one or both eyes of 30 participants (5.6%) and bilateral in 23 220 
participants (4.3%). Intermediate AMD were present in 201 participants (38%).  221 
Participants with RPD ranged in age from 33-75 years (mean 59) and there were equal 222 
numbers of males and females. The other AMD features graded as present in the 223 
participants were as follows: 352 (66%) had hyperpigmentation, 55 (10%) had 224 
hypopigmentation, 2 (0.4%) had unilateral GA, none of the participant was classified 225 
as having neovascular AMD and 183 (34%) showed other non-AMD peripheral 226 
abnormalities.  227 
 228 
Association of CAD with RPD 229 
CAD was present in 20 participants and absent in 10 participants with RPD, however, 230 
no statistically significant association between RPD and CAD was found on either the 231 
unadjusted or adjusted GEE model (p>0.05, Table 3). With respect to associations 232 
between RPD and other early AMD features a strong association was noted with 233 
intermediate AMD in the fully adjusted model (OR 3.18; 95% CI (1.61-6.27); p= 0.001). 234 
Eighteen participants had both RPD and intermediate AMD, while 11 participants had 235 
RPD alone without evidence of soft drusen.   236 
 237 
DISCUSSION 238 
We believe that our study is the first to report on the prevalence of RPD using UWF 239 
retinal images in patients with confirmed CAD. Contrary to previous reports, our study 240 
did not reveal a significant association between RPD and CAD.13-16,18  Detection of 241 
RPD was based on retinal wide field imaging and was graded using standardized 242 
protocols. We validated the ability of UWF color images to detect RPD by checking 243 
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agreement within a set of images acquired using multimodal technology and 244 
demonstrated that UWF was reliable, reproducible and robust. Our findings are in 245 
accordance with population based studies and some of the clinical cohorts that did not 246 
report significant associations between RPD and CAD or hypertension.6-8,12,24  In fact, 247 
the prevalence of RPD observed in the current SH study (30 out of 534 participants - 248 
5.6%) is similar to that reported by the population based Rotterdam study (4.9%),7 249 
providing additional support for the view that CAD is not associated with an increased 250 
prevalence of RPD. Interestingly, Zarubina et al studied patients from primary care 251 
eye clinics with and without AMD, and using multi-modal imaging and strict criteria 252 
found that the prevalence of SDD in subjects without AMD was 23%. However, utilizing 253 
expanded criteria, Zarubina et al discovered that the prevalence of SDD on any 254 
modality, closest to that of the current study, rose to 69% in subjects of with a mean 255 
age ~ 68 years. In comparison, the population in the current study had a mean age 256 
~58 years, and a SDD prevalence of only 5.6%. This is a large difference in 257 
prevalence, as Zarubina et al. utilized SD-OCT, whereas this study only used UWF, 258 
and RPD is better detected on SD-OCT, so it would be expected to have a lower 259 
prevalence on UWF.24  260 
 261 
While 80% of participants were aged over 50, a common age restriction for many AMD 262 
studies, interestingly 8 participants with RPD were aged under 50, the youngest aged 263 
33. Of these, 4 (50%) also had evidence of intermediate AMD whereas the rest had 264 
no other features of AMD present. If, as has been proposed, the primary lesion is 265 
vascular (choroidal insufficiency), then as the disease progresses the development of 266 
SDD may follow. It is possible that this may be one explanation for the findings of fewer 267 
SDD within a younger population. In the overall sample, 7 participants had RPD 268 
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without any other AMD features similar to previous observations,7 which may reflect a 269 
different phenotype given that RPD have been reported in other retinal diseases such 270 
as Sorsby fundus dystrophy, pseudoxanthoma elasticum and acquired vitelliform 271 
lesions.25-27 Given the rarity of these participants, it is likely that studies of large sample 272 
size or pooled analyses across studies will be required to improve our understanding 273 
of the relevance of these isolated RPD.  274 
 275 
The RPD phenotype in AMD has been shown to be associated with choroidal 276 
thinning28-33 and thus it has been suggested that RPD arise as a consequence of 277 
choroidal vascular pathology such as age-related atherosclerosis. Interestingly Leisy 278 
et al. recently found an association between the RPD phenotype and renal 279 
dysfunction.34 However, we were unable to establish a relationship in a large 280 
population with a diagnosis of CAD that was established using robust methodology 281 
and which constitutes an important marker for systemic vascular disease. Therefore 282 
we contend that the pathogenesis of RPD remains unresolved and we suggest that 283 
the outer photoreceptor mosaic may be the source of this material which in turn is a 284 
consequence of RPE degeneration with withdrawal of trophic/survival factors to the 285 
photoreceptors.   286 
 287 
This is only the second study, to our knowledge, that used UWF imaging for the 288 
evaluation of RPD.19 Using the NICOLA image repository we confirmed the reliability 289 
of this approach to detect reticular drusen which have been observed when using other 290 
en face modalities such as IR or AF imaging. Nonetheless we are of the view that as 291 
with other en face modalities, UWF imaging also underestimates the prevalence 292 
because the earliest stages of the SDD phenotype are best appreciated on high 293 
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resolution SD OCT.35  Stage one SDD is defined by the dispersed nature of the 294 
deposits of granular hyperreflective material  that is present in the outer retina in the 295 
region of the photoreceptors’ inner and outer segments (the IS/OS boundary) and the 296 
retinal pigment epithelium. A characteristic reticulated pattern accompanies stages 2 297 
and 3, which has been attributed to focal deposits that cause marked alterations to the 298 
IS/OS boundary and thus become detectable by en face imaging.35 Currently it is 299 
accepted that detection of RPD is best when a multimodal approach, combining IR, 300 
AF and SD-OCT is used.12,36 We were however reassured by the validation study 301 
which demonstrated the benefit of the increased field of view provided by UWF 302 
imaging. We also noted that RPD was evident in at least one participant in an area of 303 
the retinal fundus that is typically not included in color images (35 or 45) or OCT, 304 
raising the possibility of under ascertainment when the field of examination is restricted 305 
to the central fundus. 306 
 307 
A potential limitation of this study is the choice of controls as all participants (cases 308 
and controls) were recruited from cardiology clinics. However comtrol status was only 309 
assigned following an extensive and robust clinical examination, computed 310 
tomography coronary angiography and calcium scores. This cohort may therefore 311 
have characteristics that are dissimilar to that of a random population based sample. 312 
Even though we adjusted for age, sex and smoking habit, some of the established 313 
AMD risk factors, such as diet, and genetic risk, were not available and therefore 314 
residual confounding may have been present. However, concerns over residual 315 
confounding are less worrisome, given the absence of the finding of a positive 316 
association between CAD and RPD.  317 
 318 
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In conclusion, our study does not support previously reported associations with CAD. 319 
As with other studies we observed the strong association with the hallmark feature of 320 
classical drusen which is recognized as early AMD. Our findings highlight the 321 
necessity for other studies in this age group with improved phenotyping of the ocular 322 
fundus as well as vascular disease in other organ systems. Data from large and well 323 
characterized longitudinal population based studies with multimodal imaging will be 324 
required. In addition, pooled analyses of multiple studies to improve statistical power 325 
may help untangle the complexity of the risk factors and sub-phenotypes involved.   326 
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Table 1. Summary statistics for study participants. 469 
 470 
   
 
All 
participants 
n=534 
Reticular Pseudodrusen (one or 
both eyes) 
 
Absent 
n=504 
 
Present 
n=30 
 
 
p 
Age 
Mean (SD) 
 
58 (10) 
 
58 (9) 
 
59 (12) 
 
0.76 
Sex (%) 
Male 
Female 
 
299 (56) 
235 (44) 
 
284 (56) 
220 (44) 
 
15 (50) 
15 (50) 
 
 
0.57 
Body mass index 
Mean (SD) 
 
30 (7) 
 
30 (7) 
 
28 (6) 
 
0.19 
CAD diagnosis (%) 
None 
Non-obstructive to mild 
Non-obstructive to moderate 
Obstructive CAD 
Missing  
 
178 (33) 
114 (21) 
87 (16) 
150 (28) 
5 (1) 
 
168 (33) 
105 (21) 
84 (17) 
142 (28) 
5(1) 
 
10 (33) 
9 (30) 
3 (10) 
8 (27) 
0 (0) 
 
 
 
 
 
0.71 
CAD (%) 
Absent 
Present 
Missing 
 
178 (33) 
351 (66) 
5 (1) 
 
168 (33) 
331 (66) 
5 (1) 
 
10 (33) 
20 (67) 
0 (0) 
 
 
 
0.99 
Assign Score 
Mean (SD) 
 
18 (12) 
 
18 (12) 
 
17 (11) 
 
0.56 
Coronary Artery Calcium 
Score 
Mean (SD) 
 
314 (805) 
 
310 (814) 
 
376 (634) 
 
0.67 
Hypertension (%) 
No  
Yes 
Missing 
 
346 (65) 
182 (34) 
6 (1) 
 
327 (65) 
171 (34) 
6 (1) 
 
19 (63) 
11 (37) 
0 (0) 
 
 
 
0.84 
Diabetes (type1 or 2) (%) 
No  
Yes 
 
483 (90) 
51 (10) 
 
455 (90) 
49 (10) 
 
28 (93) 
2 (7) 
 
 
0.76 
Drusen >125m (%) 
Absent 
Present 
Missing 
 
330 (62) 
201 (38) 
3 (1) 
 
319 (63) 
183 (36) 
2 (1) 
 
11 (37) 
18 (60) 
1 (3) 
 
 
 
0.01 
Smoking History (%) 
Never 
Ex-smoker 
Current Smoker 
 
256 (48) 
193 (36) 
85 (16) 
 
244 (48) 
183 (36) 
77 (15) 
 
12 (40) 
10 (33) 
8 (27) 
 
 
 
0.25 
CAD, coronary artery disease. 471 
  472 
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Table 2.  Intragrader agreement for the individual age-related macular 473 
degeneration phenotypes. 474 
AMD Characteristic Kappa Range 
Zone 1        Zone 2        Zone 3 
Neovascular AMD 0.66      0.57 0.61 
Increased Pigment 0.59    0.54 0.61 
Decreased Pigment 0.66 0.55 0.62 
Geographic Atrophy 0.66 0.76 0.62 
Drusen 0.59 0.64 0.58 
Maximum Drusen Size 0.60 0.62 0.55 
Reticular Pseudodrusen 0.67 0.76 0.62 
Peripheral Abnormality NA 0.59 0.55 
Presence of other Pathology (All zones) 0.62 
AMD, age-related macular degeneration; NA, not applicable. 475 
  476 
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Table 3 – Investigation of coronary artery disease as a risk factor for reticular 477 
pseudodrusen using generalized estimating equations. 478 
 479 
 Unadjusted model Age and Sex adjusted Multivariate adjusted* 
 OR 95% CI P OR 95% CI P OR 95% CI P 
CAD 1.30 0.58-2.92 0.52 1.33 0.57-3.11 0.52 1.31 0.57-3.01 0.52 
Age    1.01 0.95-1.07 0.78 1.00 0.95-1.06 0.92 
Sex    1.51 0.67-3.40 0.32 1.40 0.62-3.14 0.42 
Drusen 
>125 m 
      3.18 1.61-6.27 0.001 
 480 
*Multivariate model was adjusted for age, sex and smoking status. 481 
  482 
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 483 
 484 
Figure 1: The Modified SOCA Grid utilized on the Optos Software. 485 
Z1 and Z2 are each divided into four quadrants: superonasal (SN), superotemporal 486 
(ST), inferotemporal (IT), and inferonasal (IN). Z3 is divided into two hemispheres 487 
(superior, inferior) using a visual extension of the horizontal cross line (yellow dashed 488 
lines). Taken from the Study-Specific Grading Procedures for OPERA, University of 489 
Wisconsin (2013).33  490 
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 491 
Figure 2: Optos ultra-widefield retinal image grading grids for specific AMD 492 
characteristics.  493 
The SOCA grid is divided into three zones: Zone 1 (posterior pole), Zone 2 (extends 494 
from Z1 to a circle through the ampullae of the vortex veins) and Zone 3 (extends from 495 
Z2 to the outer periphery). The Manchester grid was superimposed onto the SOCA 496 
grid to assess the ungradable areas. 497 
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 499 
 500 
Figure 3: Optos ultra-widefield retinal image illustrating RPD. 501 
The appearance of RPD on UWF is described as an interlacing reticular pattern, which 502 
appear superiorally in the outer macula and extend circumferentially and further. 503 
  504 
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 505 
Figure 4 shows the RPD interlacing pattern on both the UWF and fundus camera 506 
image. A. UWF pseudo color image showing RPD (black circle). B. UWF green laser 507 
imaging with RPD visible within the black circle. C. Fundus camera image with RPD 508 
within the black circle. D. UWF pseudo color image with arrows pointing to areas of 509 
RPD. E. UWF green laser imaging with arrows annotating areas of RPD. In this case 510 
RPD was detected beyond the field of view of color fundus photography. F. 511 
30 
 
Corresponding fundus camera image with no readily visible RPD within the black 512 
circle. 513 
 514 
